750 related articles for article (PubMed ID: 15989956)
1. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
2. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
3. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
4. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor.
Rocha S; Campbell KJ; Perkins ND
Mol Cell; 2003 Jul; 12(1):15-25. PubMed ID: 12887889
[TBL] [Abstract][Full Text] [Related]
5. The ARF tumour suppressor.
Gallagher SJ; Kefford RF; Rizos H
Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
[TBL] [Abstract][Full Text] [Related]
6. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
7. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
9. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
10. Life, death, and ubiquitin: taming the mule.
Shmueli A; Oren M
Cell; 2005 Jul; 121(7):963-5. PubMed ID: 15989944
[TBL] [Abstract][Full Text] [Related]
11. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
12. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.
Wang J; He X; Luo Y; Yarbrough WG
Biochem J; 2006 Jan; 393(Pt 2):489-501. PubMed ID: 16173922
[TBL] [Abstract][Full Text] [Related]
13. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
14. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
15. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Brady SN; Yu Y; Maggi LB; Weber JD
Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
17. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
18. ARF-BP1 as a potential therapeutic target.
Chen D; Brooks CL; Gu W
Br J Cancer; 2006 Jun; 94(11):1555-8. PubMed ID: 16641901
[TBL] [Abstract][Full Text] [Related]
19. Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function.
Kowalczyk D; Nakasone MA; Smith BO; Huang DT
Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35944929
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
Li Z; Day CP; Yang JY; Tsai WB; Lozano G; Shih HM; Hung MC
Cancer Res; 2004 Dec; 64(24):9080-5. PubMed ID: 15604276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]